Metabolic research / Product 08

Retatrutide

10mg vial

$199USD

Demo product · no payment or shipment will be created

For laboratory research only. This product is not intended for human consumption, medical treatment, veterinary use, or household use.

Product / 08Lyophilized vial

SS—008

10mgMetabolic research

Research use only · Demo product listing

About this product

Retatrutide (LY3437943) is an investigational triple agonist that targets GLP-1, GIP, and glucagon receptors. Research examines energy expenditure, weight-related measures, and other metabolic outcomes.

Research topics

Triple-receptor engagement
Energy-expenditure and fat-mass models
Liver-fat measures
Cardiometabolic markers

What the literature covers

Retatrutide remains under active clinical investigation, and its evidence base is still developing. Current studies compare its triple-agonist mechanism with dual-agonist approaches.

About study methods

Retatrutide study designs are still evolving. Use the latest primary source for the model, schedule, concentration, and handling procedures.

These notes are a starting point, not a laboratory protocol or medical guidance. Check the primary sources, your institution’s procedures, and applicable regulations before planning any work.